DATATRAK International, Inc.
DATATRAK International, Inc. (DTRK) Stock Competitors & Peer Comparison
See (DTRK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DTRK | $0.19 | +0.00% | 242.8K | -4.75 | -$0.04 | N/A |
| PMCUF | $89.11 | +3.02% | 9.3B | 54.67 | $1.63 | +0.48% |
| MTHRF | $11.00 | +0.00% | 7.3B | 23.91 | $0.46 | +1.26% |
| MTHRY | $4.41 | +4.26% | 5.6B | 18.35 | $0.23 | +4.97% |
| PANHF | $1.34 | -4.68% | 2.9B | 134.40 | $0.01 | N/A |
| CMPVF | $33.66 | +11.64% | 1.7B | 58.03 | $0.58 | +1.92% |
| PIAHY | $2.87 | -4.33% | 1.5B | 57.40 | $0.05 | N/A |
| CMPUY | $23.00 | -7.26% | 1.2B | 38.98 | $0.59 | N/A |
| SMSZF | $13.05 | +52.45% | 1.1B | 27.19 | $0.48 | +1.42% |
| RSLBF | $24.63 | +0.00% | 844.2M | 34.68 | $0.71 | +1.76% |
Stock Comparison
DTRK vs PMCUF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, PMCUF has a market cap of 9.3B. Regarding current trading prices, DTRK is priced at $0.19, while PMCUF trades at $89.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas PMCUF's P/E ratio is 54.67. In terms of profitability, DTRK's ROE is +0.37%, compared to PMCUF's ROE of +0.73%. Regarding short-term risk, DTRK is less volatile compared to PMCUF. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check PMCUF's competition here
DTRK vs MTHRF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, MTHRF has a market cap of 7.3B. Regarding current trading prices, DTRK is priced at $0.19, while MTHRF trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas MTHRF's P/E ratio is 23.91. In terms of profitability, DTRK's ROE is +0.37%, compared to MTHRF's ROE of +0.17%. Regarding short-term risk, DTRK and MTHRF have similar daily volatility (0.00).Check MTHRF's competition here
DTRK vs MTHRY Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, MTHRY has a market cap of 5.6B. Regarding current trading prices, DTRK is priced at $0.19, while MTHRY trades at $4.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas MTHRY's P/E ratio is 18.35. In terms of profitability, DTRK's ROE is +0.37%, compared to MTHRY's ROE of +0.13%. Regarding short-term risk, DTRK is less volatile compared to MTHRY. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check MTHRY's competition here
DTRK vs PANHF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, PANHF has a market cap of 2.9B. Regarding current trading prices, DTRK is priced at $0.19, while PANHF trades at $1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas PANHF's P/E ratio is 134.40. In terms of profitability, DTRK's ROE is +0.37%, compared to PANHF's ROE of +0.04%. Regarding short-term risk, DTRK and PANHF have similar daily volatility (0.00).Check PANHF's competition here
DTRK vs CMPVF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, CMPVF has a market cap of 1.7B. Regarding current trading prices, DTRK is priced at $0.19, while CMPVF trades at $33.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas CMPVF's P/E ratio is 58.03. In terms of profitability, DTRK's ROE is +0.37%, compared to CMPVF's ROE of +0.01%. Regarding short-term risk, DTRK is less volatile compared to CMPVF. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check CMPVF's competition here
DTRK vs PIAHY Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, PIAHY has a market cap of 1.5B. Regarding current trading prices, DTRK is priced at $0.19, while PIAHY trades at $2.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas PIAHY's P/E ratio is 57.40. In terms of profitability, DTRK's ROE is +0.37%, compared to PIAHY's ROE of +0.04%. Regarding short-term risk, DTRK and PIAHY have similar daily volatility (0.00).Check PIAHY's competition here
DTRK vs CMPUY Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, CMPUY has a market cap of 1.2B. Regarding current trading prices, DTRK is priced at $0.19, while CMPUY trades at $23.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas CMPUY's P/E ratio is 38.98. In terms of profitability, DTRK's ROE is +0.37%, compared to CMPUY's ROE of +0.01%. Regarding short-term risk, DTRK and CMPUY have similar daily volatility (0.00).Check CMPUY's competition here
DTRK vs SMSZF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, SMSZF has a market cap of 1.1B. Regarding current trading prices, DTRK is priced at $0.19, while SMSZF trades at $13.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas SMSZF's P/E ratio is 27.19. In terms of profitability, DTRK's ROE is +0.37%, compared to SMSZF's ROE of -0.36%. Regarding short-term risk, DTRK and SMSZF have similar daily volatility (0.00).Check SMSZF's competition here
DTRK vs RSLBF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, RSLBF has a market cap of 844.2M. Regarding current trading prices, DTRK is priced at $0.19, while RSLBF trades at $24.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas RSLBF's P/E ratio is 34.68. In terms of profitability, DTRK's ROE is +0.37%, compared to RSLBF's ROE of +0.24%. Regarding short-term risk, DTRK and RSLBF have similar daily volatility (0.00).Check RSLBF's competition here
DTRK vs CRWRF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, CRWRF has a market cap of 828.5M. Regarding current trading prices, DTRK is priced at $0.19, while CRWRF trades at $24.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas CRWRF's P/E ratio is 44.00. In terms of profitability, DTRK's ROE is +0.37%, compared to CRWRF's ROE of +0.07%. Regarding short-term risk, DTRK is less volatile compared to CRWRF. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check CRWRF's competition here
DTRK vs KSIOF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, KSIOF has a market cap of 362.6M. Regarding current trading prices, DTRK is priced at $0.19, while KSIOF trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas KSIOF's P/E ratio is -378.50. In terms of profitability, DTRK's ROE is +0.37%, compared to KSIOF's ROE of -0.13%. Regarding short-term risk, DTRK is less volatile compared to KSIOF. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check KSIOF's competition here
DTRK vs VHIBF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, VHIBF has a market cap of 329M. Regarding current trading prices, DTRK is priced at $0.19, while VHIBF trades at $5.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas VHIBF's P/E ratio is 57.80. In terms of profitability, DTRK's ROE is +0.37%, compared to VHIBF's ROE of +0.03%. Regarding short-term risk, DTRK and VHIBF have similar daily volatility (0.00).Check VHIBF's competition here
DTRK vs ONVVF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, ONVVF has a market cap of 306.9M. Regarding current trading prices, DTRK is priced at $0.19, while ONVVF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas ONVVF's P/E ratio is -20.00. In terms of profitability, DTRK's ROE is +0.37%, compared to ONVVF's ROE of -2.27%. Regarding short-term risk, DTRK is less volatile compared to ONVVF. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check ONVVF's competition here
DTRK vs COGZF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, COGZF has a market cap of 289M. Regarding current trading prices, DTRK is priced at $0.19, while COGZF trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas COGZF's P/E ratio is 28.17. In terms of profitability, DTRK's ROE is +0.37%, compared to COGZF's ROE of +0.29%. Regarding short-term risk, DTRK and COGZF have similar daily volatility (0.00).Check COGZF's competition here
DTRK vs SMDCF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, SMDCF has a market cap of 280.9M. Regarding current trading prices, DTRK is priced at $0.19, while SMDCF trades at $17.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas SMDCF's P/E ratio is -17.32. In terms of profitability, DTRK's ROE is +0.37%, compared to SMDCF's ROE of N/A. Regarding short-term risk, DTRK and SMDCF have similar daily volatility (0.00).Check SMDCF's competition here
DTRK vs DLHTF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, DLHTF has a market cap of 254.8M. Regarding current trading prices, DTRK is priced at $0.19, while DLHTF trades at $3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas DLHTF's P/E ratio is -17.24. In terms of profitability, DTRK's ROE is +0.37%, compared to DLHTF's ROE of -0.24%. Regarding short-term risk, DTRK and DLHTF have similar daily volatility (0.00).Check DLHTF's competition here
DTRK vs VPAHF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, VPAHF has a market cap of 188.2M. Regarding current trading prices, DTRK is priced at $0.19, while VPAHF trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas VPAHF's P/E ratio is -37.00. In terms of profitability, DTRK's ROE is +0.37%, compared to VPAHF's ROE of -0.18%. Regarding short-term risk, DTRK and VPAHF have similar daily volatility (0.00).Check VPAHF's competition here
DTRK vs SUSRF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, SUSRF has a market cap of 145.9M. Regarding current trading prices, DTRK is priced at $0.19, while SUSRF trades at $2.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas SUSRF's P/E ratio is 20.43. In terms of profitability, DTRK's ROE is +0.37%, compared to SUSRF's ROE of +0.02%. Regarding short-term risk, DTRK and SUSRF have similar daily volatility (0.00).Check SUSRF's competition here
DTRK vs RVRC Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, RVRC has a market cap of 101.4M. Regarding current trading prices, DTRK is priced at $0.19, while RVRC trades at $1.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas RVRC's P/E ratio is -0.35. In terms of profitability, DTRK's ROE is +0.37%, compared to RVRC's ROE of +0.07%. Regarding short-term risk, DTRK and RVRC have similar daily volatility (0.00).Check RVRC's competition here
DTRK vs CSAMF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, CSAMF has a market cap of 98.8M. Regarding current trading prices, DTRK is priced at $0.19, while CSAMF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas CSAMF's P/E ratio is -9.64. In terms of profitability, DTRK's ROE is +0.37%, compared to CSAMF's ROE of -0.85%. Regarding short-term risk, DTRK and CSAMF have similar daily volatility (0.00).Check CSAMF's competition here
DTRK vs TDMMF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, TDMMF has a market cap of 56.2M. Regarding current trading prices, DTRK is priced at $0.19, while TDMMF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas TDMMF's P/E ratio is -7.97. In terms of profitability, DTRK's ROE is +0.37%, compared to TDMMF's ROE of -0.24%. Regarding short-term risk, DTRK and TDMMF have similar daily volatility (0.00).Check TDMMF's competition here
DTRK vs HITC Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, HITC has a market cap of 52.8M. Regarding current trading prices, DTRK is priced at $0.19, while HITC trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas HITC's P/E ratio is -14.75. In terms of profitability, DTRK's ROE is +0.37%, compared to HITC's ROE of -0.79%. Regarding short-term risk, DTRK is less volatile compared to HITC. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check HITC's competition here
DTRK vs MDPEF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, MDPEF has a market cap of 42.6M. Regarding current trading prices, DTRK is priced at $0.19, while MDPEF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas MDPEF's P/E ratio is 0.00. In terms of profitability, DTRK's ROE is +0.37%, compared to MDPEF's ROE of N/A. Regarding short-term risk, DTRK and MDPEF have similar daily volatility (0.00).Check MDPEF's competition here
DTRK vs VASO Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, VASO has a market cap of 42.2M. Regarding current trading prices, DTRK is priced at $0.19, while VASO trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas VASO's P/E ratio is 24.00. In terms of profitability, DTRK's ROE is +0.37%, compared to VASO's ROE of +0.06%. Regarding short-term risk, DTRK is less volatile compared to VASO. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check VASO's competition here
DTRK vs EMOR Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, EMOR has a market cap of 41.3M. Regarding current trading prices, DTRK is priced at $0.19, while EMOR trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas EMOR's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to EMOR's ROE of +0.06%. Regarding short-term risk, DTRK and EMOR have similar daily volatility (0.00).Check EMOR's competition here
DTRK vs TREIF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, TREIF has a market cap of 36.6M. Regarding current trading prices, DTRK is priced at $0.19, while TREIF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas TREIF's P/E ratio is -3.46. In terms of profitability, DTRK's ROE is +0.37%, compared to TREIF's ROE of -1.90%. Regarding short-term risk, DTRK is less volatile compared to TREIF. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check TREIF's competition here
DTRK vs CRVW Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, CRVW has a market cap of 23.4M. Regarding current trading prices, DTRK is priced at $0.19, while CRVW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas CRVW's P/E ratio is -4.00. In terms of profitability, DTRK's ROE is +0.37%, compared to CRVW's ROE of +0.07%. Regarding short-term risk, DTRK is less volatile compared to CRVW. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check CRVW's competition here
DTRK vs RTNXF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, RTNXF has a market cap of 22.5M. Regarding current trading prices, DTRK is priced at $0.19, while RTNXF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas RTNXF's P/E ratio is -0.33. In terms of profitability, DTRK's ROE is +0.37%, compared to RTNXF's ROE of +75.44%. Regarding short-term risk, DTRK is less volatile compared to RTNXF. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check RTNXF's competition here
DTRK vs HDSLF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, HDSLF has a market cap of 21.1M. Regarding current trading prices, DTRK is priced at $0.19, while HDSLF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas HDSLF's P/E ratio is -3.22. In terms of profitability, DTRK's ROE is +0.37%, compared to HDSLF's ROE of -1.31%. Regarding short-term risk, DTRK is less volatile compared to HDSLF. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check HDSLF's competition here
DTRK vs THKKF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, THKKF has a market cap of 17.8M. Regarding current trading prices, DTRK is priced at $0.19, while THKKF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas THKKF's P/E ratio is -1.51. In terms of profitability, DTRK's ROE is +0.37%, compared to THKKF's ROE of -0.61%. Regarding short-term risk, DTRK and THKKF have similar daily volatility (0.00).Check THKKF's competition here
DTRK vs DGNOF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, DGNOF has a market cap of 14.7M. Regarding current trading prices, DTRK is priced at $0.19, while DGNOF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas DGNOF's P/E ratio is -3.61. In terms of profitability, DTRK's ROE is +0.37%, compared to DGNOF's ROE of +30.80%. Regarding short-term risk, DTRK is less volatile compared to DGNOF. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check DGNOF's competition here
DTRK vs MNNDF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, MNNDF has a market cap of 14.3M. Regarding current trading prices, DTRK is priced at $0.19, while MNNDF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas MNNDF's P/E ratio is -1.48. In terms of profitability, DTRK's ROE is +0.37%, compared to MNNDF's ROE of N/A. Regarding short-term risk, DTRK is less volatile compared to MNNDF. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check MNNDF's competition here
DTRK vs PBSV Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, PBSV has a market cap of 12.4M. Regarding current trading prices, DTRK is priced at $0.19, while PBSV trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas PBSV's P/E ratio is -54.00. In terms of profitability, DTRK's ROE is +0.37%, compared to PBSV's ROE of -0.00%. Regarding short-term risk, DTRK and PBSV have similar daily volatility (0.00).Check PBSV's competition here
DTRK vs CMHSF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, CMHSF has a market cap of 10.2M. Regarding current trading prices, DTRK is priced at $0.19, while CMHSF trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas CMHSF's P/E ratio is -3.79. In terms of profitability, DTRK's ROE is +0.37%, compared to CMHSF's ROE of +0.41%. Regarding short-term risk, DTRK is less volatile compared to CMHSF. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check CMHSF's competition here
DTRK vs CDXFF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, CDXFF has a market cap of 9.7M. Regarding current trading prices, DTRK is priced at $0.19, while CDXFF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas CDXFF's P/E ratio is -1.35. In terms of profitability, DTRK's ROE is +0.37%, compared to CDXFF's ROE of +0.70%. Regarding short-term risk, DTRK and CDXFF have similar daily volatility (0.00).Check CDXFF's competition here
DTRK vs BRGX Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, BRGX has a market cap of 8.7M. Regarding current trading prices, DTRK is priced at $0.19, while BRGX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas BRGX's P/E ratio is -0.90. In terms of profitability, DTRK's ROE is +0.37%, compared to BRGX's ROE of +0.40%. Regarding short-term risk, DTRK and BRGX have similar daily volatility (0.00).Check BRGX's competition here
DTRK vs HBCNF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, HBCNF has a market cap of 8.4M. Regarding current trading prices, DTRK is priced at $0.19, while HBCNF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas HBCNF's P/E ratio is -0.59. In terms of profitability, DTRK's ROE is +0.37%, compared to HBCNF's ROE of -0.57%. Regarding short-term risk, DTRK is less volatile compared to HBCNF. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check HBCNF's competition here
DTRK vs CMPD Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, CMPD has a market cap of 8.4M. Regarding current trading prices, DTRK is priced at $0.19, while CMPD trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas CMPD's P/E ratio is -14.77. In terms of profitability, DTRK's ROE is +0.37%, compared to CMPD's ROE of -0.08%. Regarding short-term risk, DTRK and CMPD have similar daily volatility (0.00).Check CMPD's competition here
DTRK vs SPLTF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, SPLTF has a market cap of 8M. Regarding current trading prices, DTRK is priced at $0.19, while SPLTF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas SPLTF's P/E ratio is -2.60. In terms of profitability, DTRK's ROE is +0.37%, compared to SPLTF's ROE of -6.63%. Regarding short-term risk, DTRK is less volatile compared to SPLTF. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check SPLTF's competition here
DTRK vs VYND Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, VYND has a market cap of 7.9M. Regarding current trading prices, DTRK is priced at $0.19, while VYND trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas VYND's P/E ratio is -43.00. In terms of profitability, DTRK's ROE is +0.37%, compared to VYND's ROE of +0.81%. Regarding short-term risk, DTRK and VYND have similar daily volatility (0.00).Check VYND's competition here
DTRK vs UDOCF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, UDOCF has a market cap of 7.6M. Regarding current trading prices, DTRK is priced at $0.19, while UDOCF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas UDOCF's P/E ratio is -2.92. In terms of profitability, DTRK's ROE is +0.37%, compared to UDOCF's ROE of +62.04%. Regarding short-term risk, DTRK and UDOCF have similar daily volatility (0.00).Check UDOCF's competition here
DTRK vs AIMLF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, AIMLF has a market cap of 7.1M. Regarding current trading prices, DTRK is priced at $0.19, while AIMLF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas AIMLF's P/E ratio is -2.11. In terms of profitability, DTRK's ROE is +0.37%, compared to AIMLF's ROE of -5.05%. Regarding short-term risk, DTRK is less volatile compared to AIMLF. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check AIMLF's competition here
DTRK vs WLSS Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, WLSS has a market cap of 6.9M. Regarding current trading prices, DTRK is priced at $0.19, while WLSS trades at $2.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas WLSS's P/E ratio is -249.00. In terms of profitability, DTRK's ROE is +0.37%, compared to WLSS's ROE of +0.33%. Regarding short-term risk, DTRK is less volatile compared to WLSS. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check WLSS's competition here
DTRK vs CRBKF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, CRBKF has a market cap of 6.8M. Regarding current trading prices, DTRK is priced at $0.19, while CRBKF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas CRBKF's P/E ratio is -1.40. In terms of profitability, DTRK's ROE is +0.37%, compared to CRBKF's ROE of +68.80%. Regarding short-term risk, DTRK and CRBKF have similar daily volatility (0.00).Check CRBKF's competition here
DTRK vs DOCRF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, DOCRF has a market cap of 6.2M. Regarding current trading prices, DTRK is priced at $0.19, while DOCRF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas DOCRF's P/E ratio is -0.11. In terms of profitability, DTRK's ROE is +0.37%, compared to DOCRF's ROE of -1.12%. Regarding short-term risk, DTRK and DOCRF have similar daily volatility (0.00).Check DOCRF's competition here
DTRK vs IQAIF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, IQAIF has a market cap of 4.9M. Regarding current trading prices, DTRK is priced at $0.19, while IQAIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas IQAIF's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to IQAIF's ROE of -0.17%. Regarding short-term risk, DTRK is less volatile compared to IQAIF. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check IQAIF's competition here
DTRK vs CBDS Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, CBDS has a market cap of 4.3M. Regarding current trading prices, DTRK is priced at $0.19, while CBDS trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas CBDS's P/E ratio is -1.49. In terms of profitability, DTRK's ROE is +0.37%, compared to CBDS's ROE of +1.34%. Regarding short-term risk, DTRK is less volatile compared to CBDS. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check CBDS's competition here
DTRK vs RQHTF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, RQHTF has a market cap of 2.6M. Regarding current trading prices, DTRK is priced at $0.19, while RQHTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas RQHTF's P/E ratio is -0.07. In terms of profitability, DTRK's ROE is +0.37%, compared to RQHTF's ROE of -2.22%. Regarding short-term risk, DTRK and RQHTF have similar daily volatility (0.00).Check RQHTF's competition here
DTRK vs NDATF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, NDATF has a market cap of 2.5M. Regarding current trading prices, DTRK is priced at $0.19, while NDATF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas NDATF's P/E ratio is -6.00. In terms of profitability, DTRK's ROE is +0.37%, compared to NDATF's ROE of -0.64%. Regarding short-term risk, DTRK and NDATF have similar daily volatility (0.00).Check NDATF's competition here
DTRK vs RYAHF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, RYAHF has a market cap of 2.2M. Regarding current trading prices, DTRK is priced at $0.19, while RYAHF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas RYAHF's P/E ratio is 0.25. In terms of profitability, DTRK's ROE is +0.37%, compared to RYAHF's ROE of +14.95%. Regarding short-term risk, DTRK and RYAHF have similar daily volatility (0.00).Check RYAHF's competition here
DTRK vs EBYH Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, EBYH has a market cap of 1.9M. Regarding current trading prices, DTRK is priced at $0.19, while EBYH trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas EBYH's P/E ratio is -5.35. In terms of profitability, DTRK's ROE is +0.37%, compared to EBYH's ROE of +0.14%. Regarding short-term risk, DTRK and EBYH have similar daily volatility (0.00).Check EBYH's competition here
DTRK vs MDXL Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, MDXL has a market cap of 1.2M. Regarding current trading prices, DTRK is priced at $0.19, while MDXL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas MDXL's P/E ratio is -0.28. In terms of profitability, DTRK's ROE is +0.37%, compared to MDXL's ROE of +0.90%. Regarding short-term risk, DTRK and MDXL have similar daily volatility (0.00).Check MDXL's competition here
DTRK vs EVAHF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, EVAHF has a market cap of 1M. Regarding current trading prices, DTRK is priced at $0.19, while EVAHF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas EVAHF's P/E ratio is -0.42. In terms of profitability, DTRK's ROE is +0.37%, compared to EVAHF's ROE of +0.78%. Regarding short-term risk, DTRK and EVAHF have similar daily volatility (0.00).Check EVAHF's competition here
DTRK vs CSOC Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, CSOC has a market cap of 968.5K. Regarding current trading prices, DTRK is priced at $0.19, while CSOC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas CSOC's P/E ratio is 0.18. In terms of profitability, DTRK's ROE is +0.37%, compared to CSOC's ROE of -4.64%. Regarding short-term risk, DTRK and CSOC have similar daily volatility (0.00).Check CSOC's competition here
DTRK vs EKGGF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, EKGGF has a market cap of 908.9K. Regarding current trading prices, DTRK is priced at $0.19, while EKGGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas EKGGF's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to EKGGF's ROE of +1.03%. Regarding short-term risk, DTRK is less volatile compared to EKGGF. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check EKGGF's competition here
DTRK vs MDBIF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, MDBIF has a market cap of 872.8K. Regarding current trading prices, DTRK is priced at $0.19, while MDBIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas MDBIF's P/E ratio is -0.14. In terms of profitability, DTRK's ROE is +0.37%, compared to MDBIF's ROE of -0.12%. Regarding short-term risk, DTRK is less volatile compared to MDBIF. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check MDBIF's competition here
DTRK vs MDRM Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, MDRM has a market cap of 765.3K. Regarding current trading prices, DTRK is priced at $0.19, while MDRM trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas MDRM's P/E ratio is -0.60. In terms of profitability, DTRK's ROE is +0.37%, compared to MDRM's ROE of +0.42%. Regarding short-term risk, DTRK and MDRM have similar daily volatility (0.00).Check MDRM's competition here
DTRK vs MITI Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, MITI has a market cap of 634.8K. Regarding current trading prices, DTRK is priced at $0.19, while MITI trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas MITI's P/E ratio is -0.43. In terms of profitability, DTRK's ROE is +0.37%, compared to MITI's ROE of -0.02%. Regarding short-term risk, DTRK is less volatile compared to MITI. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check MITI's competition here
DTRK vs MDNWF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, MDNWF has a market cap of 517.3K. Regarding current trading prices, DTRK is priced at $0.19, while MDNWF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas MDNWF's P/E ratio is -0.02. In terms of profitability, DTRK's ROE is +0.37%, compared to MDNWF's ROE of -1.53%. Regarding short-term risk, DTRK and MDNWF have similar daily volatility (0.00).Check MDNWF's competition here
DTRK vs PPJE Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, PPJE has a market cap of 445.2K. Regarding current trading prices, DTRK is priced at $0.19, while PPJE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas PPJE's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to PPJE's ROE of -0.00%. Regarding short-term risk, DTRK and PPJE have similar daily volatility (0.00).Check PPJE's competition here
DTRK vs CTVEF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, CTVEF has a market cap of 418.1K. Regarding current trading prices, DTRK is priced at $0.19, while CTVEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas CTVEF's P/E ratio is -0.16. In terms of profitability, DTRK's ROE is +0.37%, compared to CTVEF's ROE of +0.17%. Regarding short-term risk, DTRK and CTVEF have similar daily volatility (0.00).Check CTVEF's competition here
DTRK vs ACHKF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, ACHKF has a market cap of 377.4K. Regarding current trading prices, DTRK is priced at $0.19, while ACHKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas ACHKF's P/E ratio is -0.05. In terms of profitability, DTRK's ROE is +0.37%, compared to ACHKF's ROE of +2.16%. Regarding short-term risk, DTRK and ACHKF have similar daily volatility (0.00).Check ACHKF's competition here
DTRK vs LVCE Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, LVCE has a market cap of 357.2K. Regarding current trading prices, DTRK is priced at $0.19, while LVCE trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas LVCE's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to LVCE's ROE of N/A. Regarding short-term risk, DTRK is less volatile compared to LVCE. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check LVCE's competition here
DTRK vs RSLT Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, RSLT has a market cap of 347.5K. Regarding current trading prices, DTRK is priced at $0.19, while RSLT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas RSLT's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to RSLT's ROE of N/A. Regarding short-term risk, DTRK is less volatile compared to RSLT. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check RSLT's competition here
DTRK vs NHIQ Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, NHIQ has a market cap of 329.7K. Regarding current trading prices, DTRK is priced at $0.19, while NHIQ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas NHIQ's P/E ratio is -0.00. In terms of profitability, DTRK's ROE is +0.37%, compared to NHIQ's ROE of +0.35%. Regarding short-term risk, DTRK is less volatile compared to NHIQ. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check NHIQ's competition here
DTRK vs USPS Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, USPS has a market cap of 215.1K. Regarding current trading prices, DTRK is priced at $0.19, while USPS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas USPS's P/E ratio is -1.36. In terms of profitability, DTRK's ROE is +0.37%, compared to USPS's ROE of +0.62%. Regarding short-term risk, DTRK and USPS have similar daily volatility (0.00).Check USPS's competition here
DTRK vs EWLL Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, EWLL has a market cap of 185.1K. Regarding current trading prices, DTRK is priced at $0.19, while EWLL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas EWLL's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to EWLL's ROE of +0.13%. Regarding short-term risk, DTRK and EWLL have similar daily volatility (0.00).Check EWLL's competition here
DTRK vs ALDNF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, ALDNF has a market cap of 160.4K. Regarding current trading prices, DTRK is priced at $0.19, while ALDNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas ALDNF's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to ALDNF's ROE of +0.55%. Regarding short-term risk, DTRK and ALDNF have similar daily volatility (0.00).Check ALDNF's competition here
DTRK vs TSTTF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, TSTTF has a market cap of 145.8K. Regarding current trading prices, DTRK is priced at $0.19, while TSTTF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas TSTTF's P/E ratio is -0.73. In terms of profitability, DTRK's ROE is +0.37%, compared to TSTTF's ROE of -0.02%. Regarding short-term risk, DTRK and TSTTF have similar daily volatility (0.00).Check TSTTF's competition here
DTRK vs EMYSF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, EMYSF has a market cap of 142.2K. Regarding current trading prices, DTRK is priced at $0.19, while EMYSF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas EMYSF's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to EMYSF's ROE of +2.20%. Regarding short-term risk, DTRK and EMYSF have similar daily volatility (0.00).Check EMYSF's competition here
DTRK vs DSOL Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, DSOL has a market cap of 88.9K. Regarding current trading prices, DTRK is priced at $0.19, while DSOL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas DSOL's P/E ratio is -0.01. In terms of profitability, DTRK's ROE is +0.37%, compared to DSOL's ROE of +0.03%. Regarding short-term risk, DTRK and DSOL have similar daily volatility (0.00).Check DSOL's competition here
DTRK vs NEWUF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, NEWUF has a market cap of 86.6K. Regarding current trading prices, DTRK is priced at $0.19, while NEWUF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas NEWUF's P/E ratio is -0.02. In terms of profitability, DTRK's ROE is +0.37%, compared to NEWUF's ROE of +0.88%. Regarding short-term risk, DTRK and NEWUF have similar daily volatility (0.00).Check NEWUF's competition here
DTRK vs PASO Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, PASO has a market cap of 74.1K. Regarding current trading prices, DTRK is priced at $0.19, while PASO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas PASO's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to PASO's ROE of +6.20%. Regarding short-term risk, DTRK and PASO have similar daily volatility (0.00).Check PASO's competition here
DTRK vs LFCOF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, LFCOF has a market cap of 63.4K. Regarding current trading prices, DTRK is priced at $0.19, while LFCOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas LFCOF's P/E ratio is -0.04. In terms of profitability, DTRK's ROE is +0.37%, compared to LFCOF's ROE of +8.70%. Regarding short-term risk, DTRK and LFCOF have similar daily volatility (0.00).Check LFCOF's competition here
DTRK vs REFG Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, REFG has a market cap of 60.8K. Regarding current trading prices, DTRK is priced at $0.19, while REFG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas REFG's P/E ratio is -0.01. In terms of profitability, DTRK's ROE is +0.37%, compared to REFG's ROE of +0.01%. Regarding short-term risk, DTRK and REFG have similar daily volatility (0.00).Check REFG's competition here
DTRK vs SOFE Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, SOFE has a market cap of 45.1K. Regarding current trading prices, DTRK is priced at $0.19, while SOFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas SOFE's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to SOFE's ROE of +0.52%. Regarding short-term risk, DTRK and SOFE have similar daily volatility (0.00).Check SOFE's competition here
DTRK vs HDVY Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, HDVY has a market cap of 41.2K. Regarding current trading prices, DTRK is priced at $0.19, while HDVY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas HDVY's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to HDVY's ROE of +15.89%. Regarding short-term risk, DTRK and HDVY have similar daily volatility (0.00).Check HDVY's competition here
DTRK vs IGRW Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, IGRW has a market cap of 39.8K. Regarding current trading prices, DTRK is priced at $0.19, while IGRW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas IGRW's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to IGRW's ROE of -2.28%. Regarding short-term risk, DTRK and IGRW have similar daily volatility (0.00).Check IGRW's competition here
DTRK vs WMGR Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, WMGR has a market cap of 36.3K. Regarding current trading prices, DTRK is priced at $0.19, while WMGR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas WMGR's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to WMGR's ROE of +0.53%. Regarding short-term risk, DTRK and WMGR have similar daily volatility (0.00).Check WMGR's competition here
DTRK vs SSYNF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, SSYNF has a market cap of 33.3K. Regarding current trading prices, DTRK is priced at $0.19, while SSYNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas SSYNF's P/E ratio is -0.00. In terms of profitability, DTRK's ROE is +0.37%, compared to SSYNF's ROE of N/A. Regarding short-term risk, DTRK and SSYNF have similar daily volatility (0.00).Check SSYNF's competition here
DTRK vs ORHB Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, ORHB has a market cap of 27.5K. Regarding current trading prices, DTRK is priced at $0.19, while ORHB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas ORHB's P/E ratio is -0.02. In terms of profitability, DTRK's ROE is +0.37%, compared to ORHB's ROE of +1.70%. Regarding short-term risk, DTRK and ORHB have similar daily volatility (0.00).Check ORHB's competition here
DTRK vs TTBLF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, TTBLF has a market cap of 26.7K. Regarding current trading prices, DTRK is priced at $0.19, while TTBLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas TTBLF's P/E ratio is -0.00. In terms of profitability, DTRK's ROE is +0.37%, compared to TTBLF's ROE of -1.03%. Regarding short-term risk, DTRK is less volatile compared to TTBLF. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check TTBLF's competition here
DTRK vs NMXS Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, NMXS has a market cap of 26.4K. Regarding current trading prices, DTRK is priced at $0.19, while NMXS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas NMXS's P/E ratio is -0.07. In terms of profitability, DTRK's ROE is +0.37%, compared to NMXS's ROE of -2.50%. Regarding short-term risk, DTRK and NMXS have similar daily volatility (0.00).Check NMXS's competition here
DTRK vs FDBH Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, FDBH has a market cap of 25K. Regarding current trading prices, DTRK is priced at $0.19, while FDBH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas FDBH's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to FDBH's ROE of +0.32%. Regarding short-term risk, DTRK and FDBH have similar daily volatility (0.00).Check FDBH's competition here
DTRK vs NHEL Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, NHEL has a market cap of 16.2K. Regarding current trading prices, DTRK is priced at $0.19, while NHEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas NHEL's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to NHEL's ROE of +7.36%. Regarding short-term risk, DTRK and NHEL have similar daily volatility (0.00).Check NHEL's competition here
DTRK vs BNVIF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, BNVIF has a market cap of 13.3K. Regarding current trading prices, DTRK is priced at $0.19, while BNVIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas BNVIF's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to BNVIF's ROE of -4.34%. Regarding short-term risk, DTRK is less volatile compared to BNVIF. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check BNVIF's competition here
DTRK vs HLTT Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, HLTT has a market cap of 10.7K. Regarding current trading prices, DTRK is priced at $0.19, while HLTT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas HLTT's P/E ratio is -0.00. In terms of profitability, DTRK's ROE is +0.37%, compared to HLTT's ROE of +1789941.38%. Regarding short-term risk, DTRK and HLTT have similar daily volatility (0.00).Check HLTT's competition here
DTRK vs CGNSF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, CGNSF has a market cap of 9K. Regarding current trading prices, DTRK is priced at $0.19, while CGNSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas CGNSF's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to CGNSF's ROE of +0.96%. Regarding short-term risk, DTRK and CGNSF have similar daily volatility (0.00).Check CGNSF's competition here
DTRK vs MOSTQ Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, MOSTQ has a market cap of 8.5K. Regarding current trading prices, DTRK is priced at $0.19, while MOSTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas MOSTQ's P/E ratio is -0.00. In terms of profitability, DTRK's ROE is +0.37%, compared to MOSTQ's ROE of +2.26%. Regarding short-term risk, DTRK and MOSTQ have similar daily volatility (0.00).Check MOSTQ's competition here
DTRK vs ACNV Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, ACNV has a market cap of 8.1K. Regarding current trading prices, DTRK is priced at $0.19, while ACNV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas ACNV's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to ACNV's ROE of +0.85%. Regarding short-term risk, DTRK and ACNV have similar daily volatility (0.00).Check ACNV's competition here
DTRK vs AHGIF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, AHGIF has a market cap of 7.8K. Regarding current trading prices, DTRK is priced at $0.19, while AHGIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas AHGIF's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to AHGIF's ROE of -2.79%. Regarding short-term risk, DTRK and AHGIF have similar daily volatility (0.00).Check AHGIF's competition here
DTRK vs BBLNF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, BBLNF has a market cap of 2.6K. Regarding current trading prices, DTRK is priced at $0.19, while BBLNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas BBLNF's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to BBLNF's ROE of +1.06%. Regarding short-term risk, DTRK and BBLNF have similar daily volatility (0.00).Check BBLNF's competition here
DTRK vs ICCO Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, ICCO has a market cap of 2K. Regarding current trading prices, DTRK is priced at $0.19, while ICCO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas ICCO's P/E ratio is -0.01. In terms of profitability, DTRK's ROE is +0.37%, compared to ICCO's ROE of +0.17%. Regarding short-term risk, DTRK is less volatile compared to ICCO. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check ICCO's competition here
DTRK vs HSCHF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, HSCHF has a market cap of 1.2K. Regarding current trading prices, DTRK is priced at $0.19, while HSCHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas HSCHF's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to HSCHF's ROE of +1.98%. Regarding short-term risk, DTRK and HSCHF have similar daily volatility (0.00).Check HSCHF's competition here
DTRK vs PCYS Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, PCYS has a market cap of 1.1K. Regarding current trading prices, DTRK is priced at $0.19, while PCYS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas PCYS's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to PCYS's ROE of -2.71%. Regarding short-term risk, DTRK is less volatile compared to PCYS. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check PCYS's competition here
DTRK vs CNONF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, CNONF has a market cap of 1.1K. Regarding current trading prices, DTRK is priced at $0.19, while CNONF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas CNONF's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to CNONF's ROE of +1.60%. Regarding short-term risk, DTRK and CNONF have similar daily volatility (0.00).Check CNONF's competition here
DTRK vs OLMM Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, OLMM has a market cap of 1K. Regarding current trading prices, DTRK is priced at $0.19, while OLMM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas OLMM's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to OLMM's ROE of +4.54%. Regarding short-term risk, DTRK is less volatile compared to OLMM. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check OLMM's competition here
DTRK vs ETAOF Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, ETAOF has a market cap of 512. Regarding current trading prices, DTRK is priced at $0.19, while ETAOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas ETAOF's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to ETAOF's ROE of -13.69%. Regarding short-term risk, DTRK is less volatile compared to ETAOF. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check ETAOF's competition here
DTRK vs LGBI Comparison May 2026
DTRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DTRK stands at 242.8K. In comparison, LGBI has a market cap of 50. Regarding current trading prices, DTRK is priced at $0.19, while LGBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DTRK currently has a P/E ratio of -4.75, whereas LGBI's P/E ratio is N/A. In terms of profitability, DTRK's ROE is +0.37%, compared to LGBI's ROE of +0.00%. Regarding short-term risk, DTRK is less volatile compared to LGBI. This indicates potentially lower risk in terms of short-term price fluctuations for DTRK.Check LGBI's competition here